Why Your Participation in AAD COVID-19 Registry Matters | News | APMA
Why Your Participation in AAD COVID-19 Registry Matters

May 26, 2020

COVID Toes illustration with red lesions on feet

APMA is working closely with the American Academy of Dermatology (AAD) on its established COVID-19 registry, www.aad.org/covidregistry. APMA encourages its members to report cases of lesions on the feet associated with COVID-19 through this registry because it could have immediate and long-term strategic benefits for our profession.

“The emergence of so-called 'COVID Toes' is an opportunity for our profession to both contribute meaningful data as well as assist with research, publish papers, and collaborate with another medical specialty in education and research opportunities. Developing peer-to-peer relationships with the house of medicine can also open other doors for advocacy and education,” APMA President Seth Rubenstein, DPM, said. The Principal Investigator of the AAD Registry, Esther Freeman, MD, PhD, shared that, “We have seen a broad range of cutaneous manifestations in COVID-19, many of which involve the extremities and acral surfaces. We look forward to collaborating with our colleagues from the APMA.”

The AAD COVID Registry is HIPAA-compliant and Institutional Review Board (IRB)-approved. For more information, review all our resources on COVID toes.

Leave Your Thoughts

Please sign in to leave a comment

Related Resources

APMA Joins Forces with Alira Health to Advance APMA Registry

Learn More

Introducing APMA Weekly Focus Sponsor: Ortho Dermatologics

Learn More

Make a difference for your profession on Capitol Hill. Contribute to APMAPAC.